ResearcherHarbin Institute of TechnologyActive in the last 2 years
Huanjie Yang
Matched on ORCID iD 0000-0001-8320-2182; OpenAlex author ID A5101595483. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 0, last author 6)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 10
2017: 1 paper · 2018: none · 2019: 2 papers · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper
Papers 7
- SLC7A11-AS1 contributes to prolonged activation of activin A/Smad signaling by suppressing PPM1A myristoylation in pancreatic cancer. Last author DOI 10.1038/s41416-025-03149-4↗
- Chemoresistance Transmission via Exosome-Transferred MMP14 in Pancreatic Cancer. Last author DOI 10.3389/fonc.2022.844648↗
- Metallothionein-1G suppresses pancreatic cancer cell stemness by limiting activin A secretion via NF-κB inhibition. Last author DOI 10.7150/thno.51976↗
- lncRNA SLC7A11-AS1 Promotes Chemoresistance by Blocking SCFβ-TRCP-Mediated Degradation of NRF2 in Pancreatic Cancer. Last author DOI 10.1016/j.omtn.2019.11.035↗
- Author Correction: Linc-DYNC2H1-4 promotes EMT and CSC phenotypes by acting as a sponge of miR-145 in pancreatic cancer cells. Last author DOI 10.1038/s41419-019-1852-2↗
- Pharmacometabolomics Identifies 3-Hydroxyadipic Acid, d-Galactose, Lysophosphatidylcholine (P-16:0), and Tetradecenoyl-l-Carnitine as Potential Predictive Indi… Co-author DOI 10.3389/fonc.2019.01524↗
- Linc-DYNC2H1-4 promotes EMT and CSC phenotypes by acting as a sponge of miR-145 in pancreatic cancer cells. Last author DOI 10.1038/cddis.2017.311↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Kai Li · 6 shared papers, 2017–2025 · strength 0.84
- Paper SLC7A11-AS1 contributes to prolonged activation of activin A/Smad signaling by suppressing PPM1A myristoylation in panc… DOI 10.1038/s41416-025-03149-4↗
- Paper Chemoresistance Transmission via Exosome-Transferred MMP14 in Pancreatic Cancer. DOI 10.3389/fonc.2022.844648↗
- Paper lncRNA SLC7A11-AS1 Promotes Chemoresistance by Blocking SCFβ-TRCP-Mediated Degradation of NRF2 in Pancreatic Cancer. DOI 10.1016/j.omtn.2019.11.035↗
- Qingzhu Yang · 5 shared papers, 2017–2025 · strength 0.67
- Paper SLC7A11-AS1 contributes to prolonged activation of activin A/Smad signaling by suppressing PPM1A myristoylation in panc… DOI 10.1038/s41416-025-03149-4↗
- Paper lncRNA SLC7A11-AS1 Promotes Chemoresistance by Blocking SCFβ-TRCP-Mediated Degradation of NRF2 in Pancreatic Cancer. DOI 10.1016/j.omtn.2019.11.035↗
- Paper Metallothionein-1G suppresses pancreatic cancer cell stemness by limiting activin A secretion via NF-κB inhibition. DOI 10.7150/thno.51976↗
- Huan Nie · 1 shared paper, 2025 · strength 0.27
- Mengmeng Li · 1 shared paper, 2025 · strength 0.27
- Xinyuan Li · 2 shared papers, 2019–2022 · strength 0.27
- Yuran Gao · 2 shared papers, 2017–2019 · strength 0.17
- Xuefei Guo · 1 shared paper, 2021 · strength 0.11
- Hui Li · 1 shared paper, 2019 · strength 0.09
- Dongyuan Wu · 1 shared paper, 2019 · strength 0.09
- Mei Dong · 1 shared paper, 2019 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.